4 June, 2026
In a landmark display of unity, the European Respiratory Society (ERS) has joined forces with nearly 500 prominent organizations, healthcare experts, researchers, and patient advocates to issue an urgent ultimatum to European Union leadership. As negotiations regarding the next Multiannual Financial Framework (MFF)—the EU’s long-term budget blueprint—reach a fever pitch, the coalition is demanding that public health be elevated from a peripheral policy concern to a formalized, strategic priority.
The core of their demand is both simple and non-negotiable: the establishment of a dedicated, ringfenced EU budget for health. This coalition argues that the current fragmentation of health funding is not merely a bureaucratic oversight, but a structural risk to the continent’s economic stability and social cohesion.
The Core Argument: Health as the Foundation of Competitiveness
The joint letter, addressed to European Commission President Ursula von der Leyen, European Council President António Costa, and the governments of EU Member States, strikes a tone of profound urgency. The signatories posit that Europe’s current obsession with "competitiveness, resilience, and economic security" is fundamentally flawed if it ignores the biological engine of the economy: the health of its citizens.
The argument presented is one of economic pragmatism. According to the World Health Organization (WHO), Europe suffers an staggering annual loss of €442 billion in productivity attributable to avoidable deaths from non-communicable diseases (NCDs) alone. For the ERS and its partners, this is not just a public health failure; it is a massive, preventable leak in the European economy.
"Europe cannot build a competitive economy without a healthy population," the coalition asserts. By failing to ringfence health funding, the EU risks slipping into a cycle of reactive crisis management, ignoring the long-term gains that could be achieved through preventative care, robust infrastructure, and collaborative research.
Chronology of the MFF Negotiations
The current push for a dedicated health budget is the culmination of a broader debate regarding the future of the EU’s financial architecture.
- Early 2026: As the European Commission began drafting the preliminary outlines for the post-2027 MFF, health advocates noted a concerning trend: health appeared to be drifting downward on the list of political priorities, sidelined by defense, climate transition, and digital transformation agendas.
- Spring 2026: The European Parliament took a definitive stance, adopting a position that provided a glimmer of hope for the health community. The Parliament officially backed the creation of a dedicated health budget, proposing a landmark investment of €10 billion. This served as a catalyst for the current, broader mobilization of civil society.
- June 2026: The current "joint letter" action represents the largest coordinated effort by the health sector to date. It is timed specifically to influence the European Council—the body representing Member State governments—which now holds the keys to the final negotiations.
- The Months Ahead: The late summer and autumn of 2026 are expected to be defined by intense back-room maneuvering. While some Member States have signaled a willingness to prioritize health, a broad, pan-European consensus remains elusive. The coalition is now mobilizing its full weight to pressure national capitals to ensure health is not traded away during the final budget horse-trading.
The Economic and Social Data: The Cost of Inaction
The coalition’s case is bolstered by an overwhelming volume of data, which they argue proves that "prevention is cheaper than the cure."
The Productivity Gap
The €442 billion annual productivity loss cited by the WHO is not a static figure; it is a growing burden on the European workforce. As the European population ages, the prevalence of NCDs—such as respiratory illnesses, cardiovascular diseases, and cancers—poses a direct threat to labor market participation.
The Strategic Vulnerability
Beyond productivity, the COVID-19 pandemic served as a painful lesson in the dangers of fragmented health policy. The coalition argues that without a centralized, ringfenced budget, the EU lacks the agility to respond to cross-border health threats, supply chain disruptions for medicines, and the persistent inequalities in healthcare access across Member States.
The Return on Investment (ROI)
Economic analyses commissioned by various academic partners in the coalition suggest that for every euro invested in preventive health, the return in avoided long-term care costs and improved economic output is significantly higher. The "cost of inaction" is described in the letter as a compounding interest rate of misery and economic stagnation that future generations of Europeans will be forced to pay.
Official Responses and The Voice of Leadership
The advocacy campaign has been spearheaded by figures like Prof. Barbara Hoffmann, Chair of the ERS Advocacy Council. Her statement reflects the frustration of a scientific community that feels their expertise is being ignored in favor of short-term fiscal targets.
"Health is not a luxury—it is a human right," Prof. Hoffmann stated in response to the launch of the letter. "It is paramount that the importance of health is recognised as a priority area in the next MFF, with its own ringfenced budget allocated. Without this, Europe’s future is at risk, given the public health and economic implications of a failure to act."
She further emphasized the moral and fiscal imperative: "Spending for health and prevention may seem significant now, but the cost of inaction will be much higher in the future. I urge EU leaders and Member States to take this opportunity to play their part in protecting the future health of European citizens."
While the Commission and Council have yet to provide a formal, unified response to this specific wave of pressure, internal sources suggest that the €10 billion proposal from the Parliament is being "carefully reviewed." However, critics note that a "review" is often a diplomatic way of signaling potential dilution in the face of competing national interests.
Implications: A Crossroads for European Integration
The implications of this struggle extend far beyond the balance sheets of the next seven-year budget. This is a litmus test for the "European Health Union" concept that was championed in the wake of the pandemic.
The Integration Test
If the EU fails to allocate a dedicated, ringfenced budget for health, it effectively admits that public health remains a purely national competency, rendering the "European Health Union" a rhetorical device rather than a functional reality. Conversely, a successful push for a ringfenced budget would mark a significant shift in European integration, signaling that health is now a core pillar of the Union, alongside the single market and defense.
The Political Fallout
For the signatories of the letter—which include some of the most influential medical and scientific bodies in the world—a rejection of their proposal will have political consequences. These organizations represent millions of healthcare workers, patients, and researchers. Their unified stance suggests that the health community is no longer willing to be a secondary stakeholder in EU policy. Should the Council reject the proposal, the coalition is prepared to escalate its advocacy, potentially bringing the debate into the national political arenas of individual Member States.
The Long-Term Economic Strategy
The current debate also highlights a fundamental tension in European governance: the tension between austerity and investment. Those opposed to a ringfenced health budget argue that it creates a "silo" and reduces the flexibility of the EU budget. The coalition counters that without such a silo, health funding is the first to be sacrificed when fiscal pressures mount.
Conclusion: A Defining Moment for the Union
As the 2026 MFF negotiations proceed, the pressure on EU leadership will only intensify. The ERS and its nearly 500 partners have provided a clear, evidence-based roadmap for a healthier and more prosperous Europe. They have shifted the narrative from "charity" to "competitiveness," and from "expense" to "investment."
The decision now rests with the leaders of the 27 Member States. They must decide if the future of the European Union will be one that protects its greatest asset—its people—or one that leaves its health to the volatility of fragmented, inconsistent, and underfunded national policies.
For the European health community, the message is clear: the budget is not just a technical document; it is a moral and strategic statement. In the words of the coalition, the time for half-measures has passed. Europe’s health, and by extension its economic future, depends on the courage to invest today in the resilience of tomorrow.
For more information on the joint letter and to track the progress of this advocacy campaign, please visit the European Cancer Organisation’s policy portal or the official ERS advocacy pages.
